Vol 26, No 2 (2021)
Research paper
Published online: 2021-03-08

open access

Page views 817
Article views/downloads 670
Get Citation

Connect on Social Media

Connect on Social Media

Influence of hyperbaric oxygen therapy on bone metabolism in patients with neoplasm

Zaida Salmón-González1, Javier Anchuelo2, Juan C. Borregán3, Alvaro Del Real1, José A. Riancho1, Carmen Valero1
Rep Pract Oncol Radiother 2021;26(2):163-169.

Abstract

Background: Hyperbaric oxygen therapy (HBOT) is useful in the treatment of complications due to radiotherapy in patients with neoplasm. Its effects on bone metabolism are unclear. In our study, we analyzed the effects of HBOT on bone remodeling in oncological patients with radiotherapy.

Materials and methods: Prospective clinical study in 23 patients with neoplasms undergoing treatment with HBOT due to complications of radiotherapy (hemorrhagic cystitis, proctitis or radionecrosis) and 25 patients with chronic anal fissure. The average number of HBOT sessions was 20 ± 5 (100% oxygen, 2.3 atmospheres and 90 min per day). Serum levels of aminoterminal propeptide of type I collagen (P1NP), C terminal telopeptide of type I collagen (CTX), alkaline phosphatase (AP), 25hydroxyvitamin D (25-OHD), parathyroid hormone (PTH), were measured at 3 time points: T0 (before beginning HBOT), T1 (at the end of HBOT) and T2 (6 months after HBOT).

Results: At baseline, the patients with neoplasm have higher bone turnover than those with anal fissure. These differences were 41% in CTX (0.238 ± 0.202 ng/mL in neoplasm and 0.141 ± 0.116 ng/mL in fissure; p = 0.04), 30% for PTH (46 ± 36 pg/mL in neoplasm and 32 ± 17 pg/mL in fissure; p = 0.04) and 15% for alkaline phosphatase (80 ± 24 U/L in neoplasm and 68 ± 16 U/L in fissure; p = 0.04). In the group with neoplasm, the values of P1NP decreased 6% after HBOT (T0: 49 ± 31 ng/mL, T2: 46 ± 12 ng/mL; p = 0.03). Also, there were non-significant decreases in PTH (–34%) and CTX (–30%).

Conclusions: Patients with neoplasm and complications with radiotherapy have an increase in bone remodeling that may be diminished after HBOT.

Article available in PDF format

View PDF Download PDF file

References

  1. Arnett TR. Acidosis, hypoxia and bone. Arch Biochem Biophys. 2010; 503(1): 103–109.
  2. Utting JC, Flanagan AM, Brandao-Burch A, et al. Hypoxia stimulates osteoclast formation from human peripheral blood. Cell Biochem Funct. 2010; 28(5): 374–380.
  3. Al Hadi H, Smerdon GR, Fox SW. Hyperbaric oxygen therapy accelerates osteoblast differentiation and promotes bone formation. J Dent. 2015; 43(3): 382–388.
  4. Sunkari VG, Lind F, Botusan IR, et al. Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice. Wound Repair Regen. 2015; 23(1): 98–103.
  5. Al Hadi H, Smerdon GR, Fox SW. Hyperbaric oxygen therapy suppresses osteoclast formation and bone resorption. J Orthop Res. 2013; 31(11): 1839–1844.
  6. Lin SS, Ueng SWn, Niu CC, et al. Effects of hyperbaric oxygen on the osteogenic differentiation of mesenchymal stem cells. BMC Musculoskelet Disord. 2014; 15: 56.
  7. Lin SS, Ueng SWN, Niu CC, et al. Hyperbaric oxygen promotes osteogenic differentiation of bone marrow stromal cells by regulating Wnt3a/β-catenin signaling--an in vitro and in vivo study. Stem Cell Res. 2014; 12(1): 260–274.
  8. Wu D, Malda J, Crawford R, et al. Effects of hyperbaric oxygen on proliferation and differentiation of osteoblasts from human alveolar bone. Connect Tissue Res. 2007; 48(4): 206–213.
  9. Hayne D, Smith AE. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up: in regard to Clarke et al. (Int J Radiat Oncol Biol Phys 2008 Mar 12). Int J Radiat Oncol Biol Phys. 2008; 72(5): 1621; author reply 1621.
  10. Oliai C, Fisher B, Jani A, et al. Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys. 2012; 84(3): 733–740.
  11. Borab Z, Mirmanesh MD, Gantz M, et al. Systematic review of hyperbaric oxygen therapy for the treatment of radiation-induced skin necrosis. J Plast Reconstr Aesthet Surg. 2017; 70(4): 529–538.
  12. Atzeni F, Casale R, Alciati A, et al. Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study. Clin Exp Rheumatol. 2019; 37 Suppl 116(1): 63–69.
  13. Sultan A, Hanna GJ, Margalit DN, et al. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017; 22(3): 343–350.
  14. Memar MY, Yekani M, Alizadeh N, et al. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019; 109: 440–447.
  15. Bennett MH, Feldmeier J, Hampson NB, et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2005; 4(3): CD005005.
  16. Savvidou OD, Kaspiris A, Bolia IK, et al. Effectiveness of Hyperbaric Oxygen Therapy for the Management of Chronic Osteomyelitis: A Systematic Review of the Literature. Orthopedics. 2018; 41(4): 193–199.
  17. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9): 604–612.
  18. Fontana A, Delmas PD. Markers of bone turnover in bone metastases. Cancer. 2000; 88(12 Suppl): 2952–2960, doi: 10.1002/1097-0142(20000615)88:12+<2952::aid-cncr11>3.0.co;2-m.
  19. Marin L, Koivula MK, Jukkola-Vuorinen A, et al. Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases. Ann Clin Biochem. 2011; 48(Pt 5): 447–451.
  20. Higham CE, Faithfull S. Bone Health and Pelvic Radiotherapy. Clin Oncol (R Coll Radiol). 2015; 27(11): 668–678.
  21. Mavrogenis AF, Megaloikonomos PD, Panagopoulos GN, et al. Side Effects of Radiation in Bone and Cartilage: An FT-IR Analysis. J Long Term Eff Med Implants. 2015; 25(4): 289–295.
  22. Zhang J, Wang Z, Wu A, et al. Differences in responses to X-ray exposure between osteoclast and osteoblast cells. J Radiat Res. 2017; 58(6): 791–802.
  23. Oliai C, Fisher B, Jani A, et al. Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys. 2012; 84(3): 733–740.
  24. Borab Z, Mirmanesh MD, Gantz M, et al. Systematic review of hyperbaric oxygen therapy for the treatment of radiation-induced skin necrosis. J Plast Reconstr Aesthet Surg. 2017; 70(4): 529–538.
  25. Atzeni F, Casale R, Alciati A, et al. Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study. Clin Exp Rheumatol. 2019; 37 Suppl 116(1): 63–69.
  26. Adamopoulos IE. Inflammation in bone physiology and pathology. Curr Opin Rheumatol. 2018; 30(1): 59–64.
  27. Cundall JD, Gardiner A, Laden G, et al. Use of hyperbaric oxygen to treat chronic anal fissure. Br J Surg. 2003; 90(4): 452–453.



Reports of Practical Oncology and Radiotherapy